INS and type 1 diabetes mellitus: DKA is not only a life-threatening condition at the time of diagnosis, but emerging evidence demonstrates a lifelong impact on metabolic control and cognitive function.4, 9 Furthermore, insulin replacement therapy, the standard treatment for type 1 diabetes, often fails to achieve physiological glycaemic control despite significant advancements in insulin analogues, glucose monitoring and insulin delivery technologies.